News Related to ACT Capital Management

Related coverage linked through entity extraction aliases.

Biotech Sector Sees Major Investments and M&A Activity in Early 2026

Jun 08, 2026

Major biotech investment and M&A activity marked early 2026, including a significant stake purchase in TG Therapeutics and multiple high-value acquisitions within the RTW Biotech Opportunities portfolio. The sector showed improving capital markets and strategic deal interest following the JPMorgan Healthcare Conference.

Obesity Drug Market Sees Investment Activity and Regulatory Developments Across Multiple Regions

Mar 17, 2026

ACT Capital Management invested $7.25 million in Viking Therapeutics as the company advances its obesity drug candidate VK2735 into Phase 3 trials. India's drug regulator warned pharmaceutical companies against direct or surrogate advertising of weight-loss medicines, while South Korean drugmakers target year-end commercialization of domestically developed obesity treatments.